TARGETING B-CELL MALIGNANCIES WITH ANTI-ROR1 CAR T-CELL THERAPY

被引：0

作者：

Weng, Jinsheng ^{[1
]}

Agbedia, Owhofasa ^{[1
]}

Cao, Jingjing ^{[1
]}

Cheng, Xiaoyun ^{[1
]}

Kuang, Shao Qing ^{[1
]}

Chu, Fuliang ^{[1
]}

Patchv, Sridevi ^{[1
]}

Tang, Yongfu ^{[1
]}

Bansal, Divyam ^{[1
]}

Liu, Jingwei ^{[1
]}

Saini, Neeraj ^{[1
]}

Neelapu, Sattva ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0296

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

296

引用

下载

页码：A311 / A311

页数：1

共 50 条

[41] CAR T-Cell Therapy for Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Gideon, Jacklyn
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (06) : 597 - 601
[42] CAR T-Cell Therapy Against B-Cell Maturation Antigen in Multiple Myeloma
Cohen, Adam D.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (12) : 804 - 806
[43] CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?
Roschewski, Mark
Longo, Dan L.
Wilson, Wyndham H.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07): : 692 - 696
[44] CD19-directed CAR T-cell therapy in B-cell NHL
Kersten, Marie Jose
Spanjaart, Anne Mea
Thieblemont, Catherine
CURRENT OPINION IN ONCOLOGY, 2020, 32 (05) : 408 - 417
[45] Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S.
Locke, F. L.
Bartlett, N. L.
Lekakis, L. J.
Miklos, D. B.
Jacobson, C. A.
Braunschweig, I.
Oluwole, O. O.
Siddiqi, T.
Lin, Y.
Timmerman, J. M.
Stiff, P. J.
Friedberg, J. W.
Flinn, I. W.
Goy, A.
Hill, B. T.
Smith, M. R.
Deol, A.
Farooq, U.
McSweeney, P.
Munoz, J.
Avivi, I.
Castro, J. E.
Westin, J. R.
Chavez, J. C.
Ghobadi, A.
Komanduri, K. V.
Levy, R.
Jacobsen, E. D.
Witzig, T. E.
Reagan, P.
Bot, A.
Rossi, J.
Navale, L.
Jiang, Y.
Aycock, J.
Elias, M.
Chang, D.
Wiezorek, J.
Go, W. Y.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2531 - 2544
[46] CONSTITUTIONAL TRANSLOCATIONS AND PREDISPOSITION TO T-CELL AND B-CELL MALIGNANCIES
PATHAK, S
CYTOGENETICS AND CELL GENETICS, 1986, 43 (3-4): : 223 - 225
[47] DNA REARRANGEMENTS IN HUMAN B-CELL AND T-CELL MALIGNANCIES
SMITH, CIE
HAMMARSTROM, L
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1986, 3 (3-4): : 153 - 157
[48] Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
Zurko, Joanna
Ramdial, Jeremy
Shadman, Mazyar
Ahmed, Sairah
Szabo, Aniko
Iovino, Lorenzo
Tomas, Ana Alarcon
Sauter, Craig
Perales, Miguel-Angel
Shah, Nirav. N.
Acharya, Utkarsh H.
Jacobson, Caron
Soiffer, Robert J.
Wang, Trent
Komanduri, Krishna, V
Jaglowski, Samantha
Kittai, Adam S.
Denlinger, Nathan
Iqbal, Madiha
Kharfan-Dabaja, Mohamed A.
Ayala, Ernesto
Chavez, Julio
Jain, Michael
Locke, Frederick L.
Samara, Yazeed
Budde, Lihua E.
Mei, Matthew G.
Della Pia, Alexandra
Feldman, Tatyana
Ahmed, Nausheen
Jacobs, Ryan
Ghosh, Nilanjan
Dholaria, Bhagirathbhai
Oluwole, Olalekan O.
Hess, Brian
Hassan, Ayesha
Kenkre, Vaishalee P.
Reagan, Patrick
Awan, Farrukh
Nieto, Yago
Hamadani, Mehdi
Herrera, Alex F.
HAEMATOLOGICA, 2023, 108 (01) : 98 - 109
[49] Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
Wang, Na
Hu, Xuelian
Cao, Wenyue
Li, Chunrui
Xiao, Yi
Cao, Yang
Gu, Chaojiang
Zhang, Shangkun
Chen, Liting
Cheng, Jiali
Wang, Gaoxiang
Zhou, Xiaoxi
Zheng, Miao
Mao, Xia
Jiang, Lijun
Wang, Di
Wang, Qiuxiang
Lou, Yaoyao
Cai, Haodong
Yan, Dandan
Zhang, Yicheng
Zhang, Tongcun
Zhou, Jianfeng
Huang, Liang
BLOOD, 2020, 135 (01) : 17 - 27
[50] DNA REARRANGEMENT AS A MARKER OF B-CELL AND T-CELL MALIGNANCIES
HOEKMAN, K
BRAND, A
GIPHART, MJ
NETHERLANDS JOURNAL OF MEDICINE, 1987, 31 (5-6): : 241 - 250

← 1 2 3 4 5 →